- Home
- WWR vs LTRN Comparison
WWR vs LTRN Comparison
Compare WWR & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WWR | LTRN |
|---|---|---|
| Founded | 1977 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.3M | 27.6M |
| IPO Year | 2006 | 2020 |
Fundamental Metrics
Financial Performance| Metric | WWR | LTRN |
|---|---|---|
| Price | $0.59 | $1.81 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $1.92 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 137.9K |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.65 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.38 | $1.11 |
| 52 Week High | $3.75 | $4.70 |
Technical Indicators
Market Signals| Indicator | WWR | LTRN |
|---|---|---|
| Relative Strength Index (RSI) | 56.61 | 22.91 |
| Support Level | $0.56 | $1.11 |
| Resistance Level | $0.63 | $2.41 |
| Average True Range (ATR) | 0.03 | 0.18 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 63.01 | 9.27 |
Price Performance
Historical ComparisonAbout WWR Westwater Resources Inc.
Westwater Resources Inc is an energy technology company focused on developing battery-grade natural graphite materials through a vertically integrated, mine-to-market strategy anchored by its two primary projects in Coosa County, Alabama: the Kellyton Graphite Plant and the Coosa Graphite Deposit. Westwater also holds mineral rights to explore and mine the Coosa Graphite Deposit, which Westwater anticipates will eventually provide natural graphite flake concentrate as feedstock to the Kellyton Graphite Plant.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.